Novel endothelial cell markers in hepatocellular carcinoma.
about
Performance reproducibility index for classificationAn integrated data analysis approach to characterize genes highly expressed in hepatocellular carcinomaDiscovering hidden connections among diseases, genes and drugs based on microarray expression profiles with negative-term filteringPDGF-dependent regulation of regulator of G protein signaling-5 expression and vascular smooth muscle cell functionality.Multiple-rule bias in the comparison of classification rulesRadiation-guided gene therapy of cancer.Genetic variations in the regulator of G-protein signaling genes are associated with survival in late-stage non-small cell lung cancerSynergistic role of Sprouty2 inactivation and c-Met up-regulation in mouse and human hepatocarcinogenesis.Relationship between RGS5 expression and differentiation and angiogenesis of gastric carcinomaRegulator of G-protein signaling - 5 (RGS5) is a novel repressor of hedgehog signaling.Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer.Regulator of G-protein signaling-5 is a marker of hepatic stellate cells and expression mediates response to liver injuryRegulator of G-protein signaling 5 (RGS5) protein: a novel marker of cancer vasculature elicited and sustained by the tumor's proangiogenic microenvironment.Anti‑angiogenic therapy for normalization of tumor vasculature: A potential effect of Buyang Huanwu decoction on nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potentialDetection of pancreatic ductal adenocarcinoma in mice by ultrasound imaging of thymocyte differentiation antigen 1.Overexpression of regulator of G protein signaling 11 promotes cell migration and associates with advanced stages and aggressiveness of lung adenocarcinoma.Podocalyxin influences malignant potential by controlling epithelial-mesenchymal transition in lung adenocarcinoma.Involvement of platelet-tumor cell interaction in immune evasion. Potential role of podocalyxin-like protein 1.Alterations in metabolism-related genes induced in SHSY5Y cells by okadaic acid exposure.An efficient method to estimate the optimum regularization parameter in RLDA.Bmi1 functions as an oncogene independent of Ink4A/Arf repression in hepatic carcinogenesis.Coexpression network analysis in chronic hepatitis B and C hepatic lesions reveals distinct patterns of disease progression to hepatocellular carcinoma.Osteopontin is up-regulated and associated with neutrophil and macrophage infiltration in glioblastoma.Molecular profile of endothelial invasion of three-dimensional collagen matrices: insights into angiogenic sprout induction in wound healing.Thy1-Targeted Microbubbles for Ultrasound Molecular Imaging of Pancreatic Ductal Adenocarcinoma.Endothelial transdifferentiation in hepatocellular carcinoma: loss of Stabilin-2 expression in peri-tumourous liver correlates with increased survival.Regulator of G-protein signaling 5 enhances portal vein invasion in hepatocellular carcinoma.Functional modules with disease discrimination abilities for various cancers.
P2860
Q24289201-9D70B2AD-5B77-4561-A3E0-57FB2205EA20Q28237169-F98F1174-CFDA-4B8F-A539-24D7AAEAF63DQ28539530-43B954AD-A02C-4F73-8117-74ABC0E88846Q30425676-D1CFCA2E-2BCC-4A9A-8145-71061FAF001BQ30500802-6ED6BFC1-4EFE-4950-B9AD-13A99B58B97DQ33251692-DDE11DA9-C9C5-444E-8ED5-F14C94C5D684Q33940693-0517006A-5B81-489D-AFA5-4CC4D8C4814FQ34062598-F9902740-CA41-46FA-BC2A-61F907203945Q34354756-0CC14417-D053-4655-940A-2CE4F6164FCBQ34700297-333906A6-F1DF-4BFA-99F8-E33138835C40Q35287580-A2F87F76-1E69-4E02-A506-68B8DC8C5183Q35309176-10EF9D78-77DC-439A-8414-9D0F4EE73975Q35823514-44C49B04-A478-42C4-9D70-090B16BA8B9AQ36623880-711C433B-4C62-408E-8C4C-9B8F88EC341FQ37198592-D4417291-9759-494F-9D02-5C487660F297Q37327676-2870248A-C220-41FA-9D63-68C7161A8CBDQ37735632-5FF3933D-672C-4A5B-9144-A9519F98F89CQ38259585-B6BE115F-E4A2-4140-8A9E-511AD6016103Q39315901-AA692232-D410-4E27-ADC9-7B9518354D26Q39531522-FDAB3AD4-F9FF-45B7-970B-69028AEA2AB4Q39771415-3AC1BD6A-F755-40D5-A0BD-68B1D11575D6Q42978926-0B240935-06D2-45F1-8600-5010EA7395CDQ44624198-4FD34D9A-660E-4E52-BE7D-B7F12A0F2127Q46372754-75B5FB48-2D3F-429E-AB0D-01FB05F1056DQ47200008-369B4F5E-518B-4277-B756-67EFBC31EF6EQ47976287-1CADE468-152A-4F11-BB9A-64020B9C2173Q50053727-5B442717-2267-4089-B135-DAC4E83A49ECQ51603370-95D5F449-0A08-4BE6-B52C-B329B23C9096
P2860
Novel endothelial cell markers in hepatocellular carcinoma.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Novel endothelial cell markers in hepatocellular carcinoma.
@en
Novel endothelial cell markers in hepatocellular carcinoma.
@nl
type
label
Novel endothelial cell markers in hepatocellular carcinoma.
@en
Novel endothelial cell markers in hepatocellular carcinoma.
@nl
prefLabel
Novel endothelial cell markers in hepatocellular carcinoma.
@en
Novel endothelial cell markers in hepatocellular carcinoma.
@nl
P2093
P2860
P1433
P1476
Novel endothelial cell markers in hepatocellular carcinoma.
@en
P2093
John Higgins
Kelli Montgomery
Sheung-Tat Fan
Siu-Tim Cheung
Veronica Mason
P2860
P2888
P304
P356
10.1038/MODPATHOL.3800167
P577
2004-10-01T00:00:00Z